101 related articles for article (PubMed ID: 28339300)
1. Genetic Manipulation by Zinc-Finger Nucleases in Rat-Induced Pluripotent Stem Cells.
Yang S; Ding S; Xu Q; Li X; Xiong Q
Cell Reprogram; 2017 Jun; 19(3):180-188. PubMed ID: 28339300
[TBL] [Abstract][Full Text] [Related]
2. Efficient p53 gene targeting by homologous recombination in rat-induced pluripotent stem cells.
Li G; Chunxu Y; Guisheng L
Cell Prolif; 2013 Feb; 46(1):1-9. PubMed ID: 23278941
[TBL] [Abstract][Full Text] [Related]
3. In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases.
Sebastiano V; Maeder ML; Angstman JF; Haddad B; Khayter C; Yeo DT; Goodwin MJ; Hawkins JS; Ramirez CL; Batista LF; Artandi SE; Wernig M; Joung JK
Stem Cells; 2011 Nov; 29(11):1717-26. PubMed ID: 21898685
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
5. Targeted transgene insertion into the AAVS1 locus driven by baculoviral vector-mediated zinc finger nuclease expression in human-induced pluripotent stem cells.
Tay FC; Tan WK; Goh SL; Ramachandra CJ; Lau CH; Zhu H; Chen C; Du S; Phang RZ; Shahbazi M; Fan W; Wang S
J Gene Med; 2013 Oct; 15(10):384-95. PubMed ID: 24105820
[TBL] [Abstract][Full Text] [Related]
6. Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine.
Revilla A; González C; Iriondo A; Fernández B; Prieto C; Marín C; Liste I
J Tissue Eng Regen Med; 2016 Nov; 10(11):893-907. PubMed ID: 25758460
[TBL] [Abstract][Full Text] [Related]
7. Targeted, homology-driven gene insertion in stem cells by ZFN-loaded 'all-in-one' lentiviral vectors.
Cai Y; Laustsen A; Zhou Y; Sun C; Anderson MV; Li S; Uldbjerg N; Luo Y; Jakobsen MR; Mikkelsen JG
Elife; 2016 Jun; 5():. PubMed ID: 27278774
[TBL] [Abstract][Full Text] [Related]
8. Generation and Characterization of Rat iPSCs.
Liao J; Cui C
Methods Mol Biol; 2016; 1357():133-48. PubMed ID: 25687298
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
10. p53 isoform Δ133p53 promotes efficiency of induced pluripotent stem cells and ensures genomic integrity during reprogramming.
Gong L; Pan X; Chen H; Rao L; Zeng Y; Hang H; Peng J; Xiao L; Chen J
Sci Rep; 2016 Nov; 6():37281. PubMed ID: 27874035
[TBL] [Abstract][Full Text] [Related]
11. Derivation and genetic modification of embryonic stem cells from disease-model inbred rat strains.
Yang S; Takizawa A; Foeckler J; Zappa A; Gjoka M; Schilling R; Hansen C; Xu H; Kalloway S; Grzybowski M; Davis GD; Jacob HJ; Geurts AM
Stem Cells Dev; 2013 May; ():. PubMed ID: 23635087
[TBL] [Abstract][Full Text] [Related]
12. Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation.
Yi L; Lu C; Hu W; Sun Y; Levine AJ
Cancer Res; 2012 Nov; 72(21):5635-45. PubMed ID: 22964580
[TBL] [Abstract][Full Text] [Related]
13. Site-Specific Genome Engineering in Human Pluripotent Stem Cells.
Merkert S; Martin U
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347935
[TBL] [Abstract][Full Text] [Related]
14. Generation of GFAP::GFP astrocyte reporter lines from human adult fibroblast-derived iPS cells using zinc-finger nuclease technology.
Zhang PW; Haidet-Phillips AM; Pham JT; Lee Y; Huo Y; Tienari PJ; Maragakis NJ; Sattler R; Rothstein JD
Glia; 2016 Jan; 64(1):63-75. PubMed ID: 26295203
[TBL] [Abstract][Full Text] [Related]
15. MiR-138 promotes induced pluripotent stem cell generation through the regulation of the p53 signaling.
Ye D; Wang G; Liu Y; Huang W; Wu M; Zhu S; Jia W; Deng AM; Liu H; Kang J
Stem Cells; 2012 Aug; 30(8):1645-54. PubMed ID: 22696098
[TBL] [Abstract][Full Text] [Related]
16. Roles of p53 and ASF1A in the Reprogramming of Sheep Kidney Cells to Pluripotent Cells.
Shi H; Fu Q; Li G; Ren Y; Hu S; Ni W; Guo F; Shi M; Meng L; Zhang H; Qiao J; Guo Z; Chen C
Cell Reprogram; 2015 Dec; 17(6):441-52. PubMed ID: 26580119
[TBL] [Abstract][Full Text] [Related]
17. The genomic stability of induced pluripotent stem cells.
Chen Z; Zhao T; Xu Y
Protein Cell; 2012 Apr; 3(4):271-7. PubMed ID: 22528751
[TBL] [Abstract][Full Text] [Related]
18. Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges.
Seah YF; El Farran CA; Warrier T; Xu J; Loh YH
Int J Mol Sci; 2015 Dec; 16(12):28614-34. PubMed ID: 26633382
[TBL] [Abstract][Full Text] [Related]
19. Purification of functional reprogramming factors in mammalian cell using FLAG -Tag.
Han MJ; Kim HR; O'Reilly C; Kim CH
Biochem Biophys Res Commun; 2017 Oct; 492(2):154-160. PubMed ID: 28802578
[TBL] [Abstract][Full Text] [Related]
20. Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.
Huang X; Wang Y; Yan W; Smith C; Ye Z; Wang J; Gao Y; Mendelsohn L; Cheng L
Stem Cells; 2015 May; 33(5):1470-9. PubMed ID: 25702619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
